Cristina Popa
@nephroseeker.medsky.social
🩺 Nephrologist = kidney philosopher
📜History lover
🕊️ Aspiring to be better. Freethinker
📍 #NephJC executive editor
📍@KIreportsbsky.social
📍ERAkidney #ERA25 social media co-leader
#NephSky #MedSky
📜History lover
🕊️ Aspiring to be better. Freethinker
📍 #NephJC executive editor
📍@KIreportsbsky.social
📍ERAkidney #ERA25 social media co-leader
#NephSky #MedSky
Reposted by Cristina Popa
A new web-based tool called TraceOrg has been developed to accurately measure kidney, liver, and cyst volumes in patients with autosomal dominant polycystic kidney disease (ADPKD) using MRI scans. Read more in #ASNJASN: kidney.pub/JASN0904
December 1, 2025 at 6:00 PM
A new web-based tool called TraceOrg has been developed to accurately measure kidney, liver, and cyst volumes in patients with autosomal dominant polycystic kidney disease (ADPKD) using MRI scans. Read more in #ASNJASN: kidney.pub/JASN0904
Reposted by Cristina Popa
Circulating #Testican-2 and #MGT5A are Markers of #Membranous Nephropathy
#VisualAbstract by Cristina Popa
https://www.kireports.org/article/S2468-0249(25)00705-3/fulltext
#VisualAbstract by Cristina Popa
https://www.kireports.org/article/S2468-0249(25)00705-3/fulltext
December 5, 2025 at 2:00 PM
Circulating #Testican-2 and #MGT5A are Markers of #Membranous Nephropathy
#VisualAbstract by Cristina Popa
https://www.kireports.org/article/S2468-0249(25)00705-3/fulltext
#VisualAbstract by Cristina Popa
https://www.kireports.org/article/S2468-0249(25)00705-3/fulltext
🆕 #NephJCshort by @brianrifkin.bsky.social
RETREAT-FRAIL- pragmatic RCT: is less BP medication worse in octogenarians?
www.nephjc.com/news/hyperte...
RETREAT-FRAIL- pragmatic RCT: is less BP medication worse in octogenarians?
www.nephjc.com/news/hyperte...
NephJC Shorts: Hypertension and The Extreme Elderly — NephJC
The NephJC shorts version of the Hypertension medication step-down in a nursing home population from NEJM
www.nephjc.com
December 4, 2025 at 9:16 AM
Reposted by Cristina Popa
If you want to stay on top of #NephJC happenings, sign up for our once-a-week newsletter.
BONUS: If you sign up now you can vote for TOP STORIES OF 2025!!
www.nephjc.com/newsl...
December 3, 2025 at 2:57 AM
If you want to stay on top of #NephJC happenings, sign up for our once-a-week newsletter.
BONUS: If you sign up now you can vote for TOP STORIES OF 2025!!
www.nephjc.com/newsl...
T3d
Benefits may vary, and results in the general population on CV risk and mortality are still
controversial.
Overall, the results of recent studies have been mixed results. Different study populations,
end points and dosing may account for the lack of clarity. #NephJC
December 3, 2025 at 2:48 AM
Reposted by Cristina Popa
Indeed! We did not know what to expect, but hopeful. Having worked on this for over a decade, I was initially "stunned" by the result but then not really surprised given the multitude of potential effects of EPA and DHA on the cardiovasculature, and our HD patients deficiencies in it #NephJC
December 3, 2025 at 2:43 AM
Indeed! We did not know what to expect, but hopeful. Having worked on this for over a decade, I was initially "stunned" by the result but then not really surprised given the multitude of potential effects of EPA and DHA on the cardiovasculature, and our HD patients deficiencies in it #NephJC
Reposted by Cristina Popa
We did a lot of sensitivity analyses (see Supplement) using various methods of recurrent event analysis that showed consistent results. Didn't matter how you sliced the fish!
December 3, 2025 at 2:37 AM
We did a lot of sensitivity analyses (see Supplement) using various methods of recurrent event analysis that showed consistent results. Didn't matter how you sliced the fish!
Reposted by Cristina Popa
Td
Fish oils have been studied in CKD, including: #NephJC
SLE, diabetic kidney disease, IgAN, kidney stones, post kidney transplant, CKD progression
Oxidative stress and inflammatory states.
Are you a frequent fish oil prescriber?
December 3, 2025 at 2:10 AM
Td
Fish oils have been studied in CKD, including: #NephJC
SLE, diabetic kidney disease, IgAN, kidney stones, post kidney transplant, CKD progression
Oxidative stress and inflammatory states.
Are you a frequent fish oil prescriber?
Reposted by Cristina Popa
T0c
In one meta-analysis of 113 studies 🐟: #NephJC
46.0% reported statistically significant positive results (22 in🫀, 14 in🧠 & 16 in other organs)
31.0% reported results that were not statistically significant (7 in🫀, 18 in 🧠 & 10 in other)
21.2% reported a mixed results
December 3, 2025 at 2:09 AM
T0c
In one meta-analysis of 113 studies 🐟: #NephJC
46.0% reported statistically significant positive results (22 in🫀, 14 in🧠 & 16 in other organs)
31.0% reported results that were not statistically significant (7 in🫀, 18 in 🧠 & 10 in other)
21.2% reported a mixed results
Reposted by Cristina Popa
Reposted by Cristina Popa
Although, you admired the very beautiful visual abstract made by @brianrifkin.bsky.social, #NephJC team (ha, @nephroseeker.medsky.social ) loved fish oil so much that made another one, right after #KidneyWk simultaneous publication 🎣
www.nephjc.com/news/...
www.nephjc.com/news/...
December 3, 2025 at 2:04 AM
Although, you admired the very beautiful visual abstract made by @brianrifkin.bsky.social, #NephJC team (ha, @nephroseeker.medsky.social ) loved fish oil so much that made another one, right after #KidneyWk simultaneous publication 🎣
www.nephjc.com/news/...
www.nephjc.com/news/...
Reposted by Cristina Popa
The simplest rule is to be kind and inclusive while you use your wit! Here are #NephJC values, summarized by @sstoneman.bsky.social
December 3, 2025 at 2:02 AM
The simplest rule is to be kind and inclusive while you use your wit! Here are #NephJC values, summarized by @sstoneman.bsky.social
Hi, #NephJC
Cristina Popa, 🇷🇴 nephrologist
💤4 am on my timezone, a bit sleepy, but the fishy smell will keep me awake
🎄Pics from my last weekend trip to Bucharest
Cristina Popa, 🇷🇴 nephrologist
💤4 am on my timezone, a bit sleepy, but the fishy smell will keep me awake
🎄Pics from my last weekend trip to Bucharest
December 3, 2025 at 2:03 AM
Hi, #NephJC
Cristina Popa, 🇷🇴 nephrologist
💤4 am on my timezone, a bit sleepy, but the fishy smell will keep me awake
🎄Pics from my last weekend trip to Bucharest
Cristina Popa, 🇷🇴 nephrologist
💤4 am on my timezone, a bit sleepy, but the fishy smell will keep me awake
🎄Pics from my last weekend trip to Bucharest
Reposted by Cristina Popa
Holy Mackerel! 🐟
🦜Ahoy matey! Could fish oil unlock the mysteries of increased CV mortality in ESRD? 🏴☠️ #NephJC
Join us for a lively trawling trip 12/2/25 🛥️at 9pm EST
Check out the PISCES VA by @brianrifkin.bsky.social
www.nephjc.com/news/piscesva
🦜Ahoy matey! Could fish oil unlock the mysteries of increased CV mortality in ESRD? 🏴☠️ #NephJC
Join us for a lively trawling trip 12/2/25 🛥️at 9pm EST
Check out the PISCES VA by @brianrifkin.bsky.social
www.nephjc.com/news/piscesva
PISCES: The Visual Abstract — NephJC
Curious how n-3 PUFAs may cut serious cardiovascular events in dialysis? 🐟 A big signal, a big dose, and a big discussion ahead — don’t miss this #NephJC! Check out the VA made by our master Brian...
www.nephjc.com
December 1, 2025 at 6:47 PM
Holy Mackerel! 🐟
🦜Ahoy matey! Could fish oil unlock the mysteries of increased CV mortality in ESRD? 🏴☠️ #NephJC
Join us for a lively trawling trip 12/2/25 🛥️at 9pm EST
Check out the PISCES VA by @brianrifkin.bsky.social
www.nephjc.com/news/piscesva
🦜Ahoy matey! Could fish oil unlock the mysteries of increased CV mortality in ESRD? 🏴☠️ #NephJC
Join us for a lively trawling trip 12/2/25 🛥️at 9pm EST
Check out the PISCES VA by @brianrifkin.bsky.social
www.nephjc.com/news/piscesva
Reposted by Cristina Popa
Maybe the most shocking study from #KidneyWk.
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
Fish Oil in Dialysis: A Big Catch or an Empty Net — NephJC
Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?
www.nephjc.com
December 1, 2025 at 6:41 PM
Maybe the most shocking study from #KidneyWk.
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
This is so exciting 🤩
Just a reminder that many big things in medicine started from case reports
Just a reminder that many big things in medicine started from case reports
December 1, 2025 at 3:00 PM
This is so exciting 🤩
Just a reminder that many big things in medicine started from case reports
Just a reminder that many big things in medicine started from case reports
Reposted by Cristina Popa
Me too.
Unfortunately, nephrology was stagnant for too long, community docs stopped paying attention.
Now if you’re not paying attention you get left behind.
#NephJC tries to focus on new, relevant & patient centered/practice changing studies.
Plus so many ways to learn: blog, podcast, chat.
Unfortunately, nephrology was stagnant for too long, community docs stopped paying attention.
Now if you’re not paying attention you get left behind.
#NephJC tries to focus on new, relevant & patient centered/practice changing studies.
Plus so many ways to learn: blog, podcast, chat.
a pink ribbon says learned something new today
ALT: a pink ribbon says learned something new today
media.tenor.com
November 30, 2025 at 5:42 PM
Me too.
Unfortunately, nephrology was stagnant for too long, community docs stopped paying attention.
Now if you’re not paying attention you get left behind.
#NephJC tries to focus on new, relevant & patient centered/practice changing studies.
Plus so many ways to learn: blog, podcast, chat.
Unfortunately, nephrology was stagnant for too long, community docs stopped paying attention.
Now if you’re not paying attention you get left behind.
#NephJC tries to focus on new, relevant & patient centered/practice changing studies.
Plus so many ways to learn: blog, podcast, chat.
Reposted by Cristina Popa
Still full after yesterday's #Thanksgiving feast?
Be grateful & share the love to fill bellies in need
IT'S #HCWvsHunger TIME!!!
hcwvshunger.org for the 🍎 details!
🤩Team #UrineItToWinIt will shine 🤩
@kidneyboy.bsky.social
@nephroseeker.medsky.social
@hswapnil.medsky.social
@mcstarr1.bsky.social
Be grateful & share the love to fill bellies in need
IT'S #HCWvsHunger TIME!!!
hcwvshunger.org for the 🍎 details!
🤩Team #UrineItToWinIt will shine 🤩
@kidneyboy.bsky.social
@nephroseeker.medsky.social
@hswapnil.medsky.social
@mcstarr1.bsky.social
Healthcare Workers vs Hunger
Healthcare workers vs Hunger is an annual friendly competition between teams of healthcare workers to help relieve food insecurity.
hcwvshunger.org
November 28, 2025 at 7:39 PM
Still full after yesterday's #Thanksgiving feast?
Be grateful & share the love to fill bellies in need
IT'S #HCWvsHunger TIME!!!
hcwvshunger.org for the 🍎 details!
🤩Team #UrineItToWinIt will shine 🤩
@kidneyboy.bsky.social
@nephroseeker.medsky.social
@hswapnil.medsky.social
@mcstarr1.bsky.social
Be grateful & share the love to fill bellies in need
IT'S #HCWvsHunger TIME!!!
hcwvshunger.org for the 🍎 details!
🤩Team #UrineItToWinIt will shine 🤩
@kidneyboy.bsky.social
@nephroseeker.medsky.social
@hswapnil.medsky.social
@mcstarr1.bsky.social
Reposted by Cristina Popa
Join the Filtrate and Jon Barratt as he takes an IgAN inspired victory lap
FF 86 Atacicept for IgAN
www.nephjc.com/freelyfilter...
FF 86 Atacicept for IgAN
www.nephjc.com/freelyfilter...
FF 86 Atacicept for IgAN with Jon Barratt — NephJC
FF 86 Atacicept for IgAN with Jon Barratt
www.nephjc.com
November 28, 2025 at 3:01 PM
Join the Filtrate and Jon Barratt as he takes an IgAN inspired victory lap
FF 86 Atacicept for IgAN
www.nephjc.com/freelyfilter...
FF 86 Atacicept for IgAN
www.nephjc.com/freelyfilter...
Reposted by Cristina Popa
Sibeprenlimab: First @fda.gov approved therapy targeting B cells which produce the abnormal antibodies responsible for #IgAN, addressing the fundamental cause
#Nephpearls #NephSky
#VisualAbstract by @nephroseeker.medsky.social
👉🏼 www.fda.gov/drugs/news-e...
👉🏼 pubmed.ncbi.nlm.nih.gov/41211929/
#Nephpearls #NephSky
#VisualAbstract by @nephroseeker.medsky.social
👉🏼 www.fda.gov/drugs/news-e...
👉🏼 pubmed.ncbi.nlm.nih.gov/41211929/
November 27, 2025 at 2:40 AM
Sibeprenlimab: First @fda.gov approved therapy targeting B cells which produce the abnormal antibodies responsible for #IgAN, addressing the fundamental cause
#Nephpearls #NephSky
#VisualAbstract by @nephroseeker.medsky.social
👉🏼 www.fda.gov/drugs/news-e...
👉🏼 pubmed.ncbi.nlm.nih.gov/41211929/
#Nephpearls #NephSky
#VisualAbstract by @nephroseeker.medsky.social
👉🏼 www.fda.gov/drugs/news-e...
👉🏼 pubmed.ncbi.nlm.nih.gov/41211929/
Reposted by Cristina Popa
The lineup of the #TopNephrology stories is live www.nephjc.com/news/2025/11...
If you want to vote, you need to be signed up for the #NephJC Newsletter here www.nephjc.com/newsletter ASAP
If you want to vote, you need to be signed up for the #NephJC Newsletter here www.nephjc.com/newsletter ASAP
Which were the Top Nephrology Stories of 2024? — NephJC
Time to vote for the Top Stories of 2025
www.nephjc.com
November 26, 2025 at 3:55 PM
The lineup of the #TopNephrology stories is live www.nephjc.com/news/2025/11...
If you want to vote, you need to be signed up for the #NephJC Newsletter here www.nephjc.com/newsletter ASAP
If you want to vote, you need to be signed up for the #NephJC Newsletter here www.nephjc.com/newsletter ASAP
Reposted by Cristina Popa
Apixaban and warfarin being similar is also a red flag
And with LAOO is such a huge selection bias
The SAFE-D trial (pilot; pubmed.ncbi.nlm.nih.gov/39495569/) is now funded to examine apixaban properly
#NephSky
And with LAOO is such a huge selection bias
The SAFE-D trial (pilot; pubmed.ncbi.nlm.nih.gov/39495569/) is now funded to examine apixaban properly
#NephSky
Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial - PubMed
This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2025_04_09_ASN0000000000000495.mp3 …
pubmed.ncbi.nlm.nih.gov
November 26, 2025 at 11:10 PM
Apixaban and warfarin being similar is also a red flag
And with LAOO is such a huge selection bias
The SAFE-D trial (pilot; pubmed.ncbi.nlm.nih.gov/39495569/) is now funded to examine apixaban properly
#NephSky
And with LAOO is such a huge selection bias
The SAFE-D trial (pilot; pubmed.ncbi.nlm.nih.gov/39495569/) is now funded to examine apixaban properly
#NephSky
Reposted by Cristina Popa
👇Here are the proposals for the #TopNephrology stories in 2025
🔥 Remember, you can only vote for your favorites if you have subscribed to #NephJC newsletter
📬 Soon we'll send you the voting link. Check your email.
www.nephjc.com/news/2025/11...
🔥 Remember, you can only vote for your favorites if you have subscribed to #NephJC newsletter
📬 Soon we'll send you the voting link. Check your email.
www.nephjc.com/news/2025/11...
Which were the Top Nephrology Stories of 2024? — NephJC
Time to vote for the Top Stories of 2025
www.nephjc.com
November 26, 2025 at 3:45 PM
👇Here are the proposals for the #TopNephrology stories in 2025
🔥 Remember, you can only vote for your favorites if you have subscribed to #NephJC newsletter
📬 Soon we'll send you the voting link. Check your email.
www.nephjc.com/news/2025/11...
🔥 Remember, you can only vote for your favorites if you have subscribed to #NephJC newsletter
📬 Soon we'll send you the voting link. Check your email.
www.nephjc.com/news/2025/11...
It began in 2021, wondering why anyone would pick me for #NSMC. I applied in '22 and was surprised to be accepted. I’ve grown thanks to many of you (@hswapnil.medsky.social @kidneyboy.bsky.social ), though I still feel like a newcomer 😊
🙏 Grateful to be in this with @brianrifkin.bsky.social #NephJC
🙏 Grateful to be in this with @brianrifkin.bsky.social #NephJC
An announcement
www.nephjc.com/news/2025/11...
#NephJC
@kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
www.nephjc.com/news/2025/11...
#NephJC
@kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
Taking the reigns — NephJC
In April 2014, Swapnil and I launched NephJC—and within weeks we were overwhelmed by the sheer work of running a twice-monthly, Twitter-based journal club. Fortunately, we also had a deep bench of fri...
www.nephjc.com
November 26, 2025 at 3:16 AM
It began in 2021, wondering why anyone would pick me for #NSMC. I applied in '22 and was surprised to be accepted. I’ve grown thanks to many of you (@hswapnil.medsky.social @kidneyboy.bsky.social ), though I still feel like a newcomer 😊
🙏 Grateful to be in this with @brianrifkin.bsky.social #NephJC
🙏 Grateful to be in this with @brianrifkin.bsky.social #NephJC
Probably #nephsky will never see a trial comparing spironolactone with finerenone
Target emulated trial: potential benefits of finerenone in all sorts of outcomes, but we’re comparing 🔝methodology trials (FIGARO, FIDELIO) vs invetigator initiated trials
pubmed.ncbi.nlm.nih.gov/41173939/
Target emulated trial: potential benefits of finerenone in all sorts of outcomes, but we’re comparing 🔝methodology trials (FIGARO, FIDELIO) vs invetigator initiated trials
pubmed.ncbi.nlm.nih.gov/41173939/
November 25, 2025 at 11:38 AM
Probably #nephsky will never see a trial comparing spironolactone with finerenone
Target emulated trial: potential benefits of finerenone in all sorts of outcomes, but we’re comparing 🔝methodology trials (FIGARO, FIDELIO) vs invetigator initiated trials
pubmed.ncbi.nlm.nih.gov/41173939/
Target emulated trial: potential benefits of finerenone in all sorts of outcomes, but we’re comparing 🔝methodology trials (FIGARO, FIDELIO) vs invetigator initiated trials
pubmed.ncbi.nlm.nih.gov/41173939/